BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 111 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $229,956 | +12.9% | 80,124 | -25.6% | 0.00% | 0.0% |
| Q1 2023 | $203,655 | -21.2% | 107,754 | -25.0% | 0.00% | 0.0% |
| Q4 2022 | $258,595 | -26.3% | 143,664 | -30.9% | 0.00% | 0.0% |
| Q3 2022 | $351,000 | -45.2% | 207,893 | -20.2% | 0.00% | -50.0% |
| Q2 2022 | $641,000 | -43.2% | 260,484 | -36.1% | 0.00% | -33.3% |
| Q1 2022 | $1,129,000 | -29.6% | 407,423 | +35.4% | 0.00% | 0.0% |
| Q4 2021 | $1,604,000 | -36.1% | 301,002 | +1.4% | 0.00% | -50.0% |
| Q3 2021 | $2,511,000 | -50.3% | 296,806 | -28.3% | 0.01% | -45.5% |
| Q2 2021 | $5,049,000 | +69.5% | 414,187 | +237.4% | 0.01% | +37.5% |
| Q1 2021 | $2,978,000 | -26.3% | 122,766 | -2.7% | 0.01% | -33.3% |
| Q4 2020 | $4,043,000 | – | 126,140 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $110,568,000 | 2.92% |
| Boxer Capital, LLC | 2,014,858 | $64,576,000 | 2.08% |
| RA Capital Management | 2,589,904 | $83,006,000 | 1.16% |
| Artal Group S.A. | 1,646,517 | $52,771,000 | 1.13% |
| Burrage Capital Management LLC | 34,891 | $1,118,000 | 0.85% |
| Bellevue Group AG | 1,403,000 | $44,967,000 | 0.52% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 802,511 | $25,720,000 | 0.51% |
| Ikarian Capital, LLC | 293,941 | $9,421,000 | 0.42% |
| Avoro Capital Advisors LLC | 640,000 | $20,512,000 | 0.35% |
| Logos Global Management LP | 123,465 | $3,957,000 | 0.34% |